Pharmacist-Led Deprescribing of Aspirin in Older People in an Outpatient Setting
The Senior Care Pharmacist · 2024
DOI: 10.4140/tcp.n.2024.212 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Senior Care Pharmacist, 2024. Verfasst von Veronica Hernandez Ramos und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1 Ambulatory Care Pharmacy Specialist, Denver Health Medical Center, Denver, Colorado. Hauptthemen laut MEDLINE: Aspirin, Deprescriptions, Pharmacists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
In 2019, the American College of Cardiology and American Heart Association updated their joint guidelines stating low-dose aspirin should not be used on a routine basis for primary prevention of atherosclerotic cardiovascular disease (ASCVD) among people older than 70 years of age because of increased bleeding risk. 1 In addition to these updated guidelines, a statement released by the US Preventive Services Task Force in April 2022 recommends against the initiation of low-dose aspirin for primary prevention of cardiovascular disease in people 60 years of age or older. 2 Despite these updated recommendations, aspirin continues to be a common medication older patients take, providing an opportunity for a clinical pharmacist deprescribing intervention.
Objective
To identify the role of a pharmacist-led aspirin deprescribing intervention within a safety-net health system in the outpatient setting.
Methods
This project included patients 70 years of age and older who had aspirin listed as an active medication without documented ASCVD. This project assessed aspirin deprescribing rates, time spent on pharmacist outreach, and reasons for patient and/or provider refusal to discontinue aspirin.
Results
One hundred thirty-one eligible patients were contacted. Of those, 78 (60%) patients discontinued aspirin after speaking with the pharmacist, and 8 patients discontinued aspirin after a clinical pharmacist recommendation to the patient’s primary care provider (PCP). The median time spent on outreach was approximately eight minutes. Of the 6 patients who consented to the project but declined to discontinue aspirin therapy based on pharmacist intervention, 5 preferred to discuss the issue with their PCP, while 1 patient was told by an outside provider to take aspirin.
Conclusion
Results indicate the successful impact a clinical pharmacist may have in deprescribing aspirin in a high-risk population. These data may also suggest that an active and intentional approach to deprescribing is likely to be more effective than a written recommendation to providers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1 Ambulatory Care Pharmacy Specialist, Denver Health Medical Center, Denver, Colorado.
- 2 SCL Intermountain Health, Wheat Ridge, Colorado.
Zitieren
APA
Ramos, V. H., Hayes, L., Simmons, K., Trudeau, B., & Boka, A. (2024). Pharmacist-Led Deprescribing of Aspirin in Older People in an Outpatient Setting. The Senior Care Pharmacist. https://doi.org/10.4140/tcp.n.2024.212
Vancouver
Ramos VH, Hayes L, Simmons K, Trudeau B, Boka A. Pharmacist-Led Deprescribing of Aspirin in Older People in an Outpatient Setting. The Senior Care Pharmacist. 2024. doi:10.4140/tcp.n.2024.212
BibTeX
@article{Ramos2024,
author = {Ramos, Veronica Hernandez and Hayes, Laura and Simmons, Kayley and Trudeau, Brooke and Boka, Adrian},
title = {Pharmacist-Led Deprescribing of Aspirin in Older People in an Outpatient Setting},
journal = {The Senior Care Pharmacist},
year = {2024},
doi = {10.4140/tcp.n.2024.212}
}
EUVIMED